Mycobacterium tuberculosis remains the leading cause of death by a bacterial pathogen worldwide. Increasing prevalence of multidrug-resistant organisms means prioritizing identification of targets for antituberculars. 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (HsaD), part of the cholesterol metabolism operon, is vital for survival within macrophage. The C-C bond hydrolase, HsaD, has a serine protease-like catalytic triad. We tested a range of serine protease and esterase inhibitors for their effects on HsaD activity. As well as providing a potential starting point for drug development, the data provides evidence for the mechanism of C-C bond hydrolysis. This screen also provides a route to initiate development of fragment-based inhibitors. Inhibitors of HsaD, a novel target for the treatment of tuberculosis, are identified in Mycobacterium tuberculosis. © 2013 Federation of European Microbiological Societies.
CITATION STYLE
Ryan, A., Keany, S., Eleftheriadou, O., Ballet, R., Cheng, H. Y., & Sim, E. (2014, January). Mechanism-based inhibition of HsaD: A C-C bond hydrolase essential for survival of Mycobacterium tuberculosis in macrophage. FEMS Microbiology Letters. https://doi.org/10.1111/1574-6968.12302
Mendeley helps you to discover research relevant for your work.